Avanafil Market Size, Share, Growth & Industry Analysis, By Product Type (Branded Avanafil, Generic Avanafil), By Application (Erectile Dysfunction, Pulmonary Hypertension (Off-label)), By End-User (Hospitals, Clinics, Online Pharmacies, Telemedicine Providers), and Regional Analysis, 2024-2031

1 INTRODUCTION OF THE GLOBAL AVANAFIL MARKET
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL AVANAFIL MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL AVANAFIL MARKET, BY PRODUCT TYPE
6.1 Overview
6.2 Branded Avanafil
6.3 Generic Avanafil

7 GLOBAL AVANAFIL MARKET, BY APPLICATION
7.1 Overview
7.2 Erectile Dysfunction
7.3 Pulmonary Hypertension (Off-label)

8 GLOBAL AVANAFIL MARKET, BY END-USER
8.1 Overview
8.2 Hospitals
8.3 Clinics
8.4 Online Pharmacies
8.5 Telemedicine Providers

9 GLOBAL AVANAFIL MARKET, BY GEOGRAPHY
9.1 Overview

10 NORTH AMERICA
10.1 U.S.
10.2 Canada
10.3 Mexico

11 EUROPE
11.1 Germany
11.2 UK
11.3 France
11.4 Italy
11.5 Spain
11.6 Russia
11.7 Rest of Europe

12 ASIA-PACIFIC
12.1 China
12.2 Japan
12.3 India
12.4 South Korea
12.5 Rest of Asia-Pacific

13 MIDDLE EAST & AFRICA
13.1 GCC
13.2 South Africa
13.3 North Africa
13.4 Rest of Middle East & Africa

14 LATIN AMERICA
14.1 Brazil
14.2 Argentina
14.3 Rest of South America

15 GLOBAL AVANAFIL MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Industry Footprint

16 COMPANY PROFILES
16.1 Vivus, Inc.
16.1.1 Key Facts
16.1.2 Financial Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.1.5 Winning Imperatives
16.1.6 Current Focus & Strategies
16.1.7 Threat from competition
16.1.8 SWOT Analysis
16.2 Metuchen Pharmaceuticals, LLC
16.2.1 Key Facts
16.2.2 Financial Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.2.5 Winning Imperatives
16.2.6 Current Focus & Strategies
16.2.7 Threat from competition
16.2.8 SWOT Analysis
16.3 Menarini Group
16.3.1 Key Facts
16.3.2 Financial Overview
16.3.3 Product Benchmarking
16.3.4 Recent Developments
16.3.5 Winning Imperatives
16.3.6 Current Focus & Strategies
16.3.7 Threat from competition
16.3.8 SWOT Analysis
16.4 Teva Pharmaceutical Industries Ltd.
16.4.1 Key Facts
16.4.2 Financial Overview
16.4.3 Product Benchmarking
16.4.4 Recent Developments
16.4.5 Winning Imperatives
16.4.6 Current Focus & Strategies
16.4.7 Threat from competition
16.4.8 SWOT Analysis
16.5 Cipla Limited
16.5.1 Key Facts
16.5.2 Financial Overview
16.5.3 Product Benchmarking
16.5.4 Recent Developments
16.5.5 Winning Imperatives
16.5.6 Current Focus & Strategies
16.5.7 Threat from competition
16.5.8 SWOT Analysis
16.6 Torrent Pharmaceuticals
16.6.1 Key Facts
16.6.2 Financial Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.7 Zydus Lifesciences Ltd.
16.7.1 Key Facts
16.7.2 Financial Overview
16.7.3 Product Benchmarking
16.7.4 Recent Developments
16.8 Hetero Labs Ltd.
16.8.1 Key Facts
16.8.2 Financial Overview
16.8.3 Product Benchmarking
16.8.4 Recent Developments
16.9 Apotex Inc.
16.9.1 Key Facts
16.9.2 Financial Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments
16.10 Lupin Pharmaceuticals
16.10.1 Key Facts
16.10.2 Financial Overview
16.10.3 Product Benchmarking
16.10.4 Recent Developments

LIST OF TABLES

TABLE 1 Global Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 2 Global Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 3 Global Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 4 Global Avanafil Market Revenue, By Geography, 2021 – 2031 (USD Billion)
TABLE 5 North America Avanafil Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 6 North America Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 7 North America Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 8 North America Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 9 US Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 10 US Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 11 US Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 12 Canada Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 13 Canada Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 14 Canada Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 15 Mexico Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 16 Mexico Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 17 Mexico Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 18 Europe Avanafil Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 19 Europe Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 20 Europe Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 21 Europe Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 22 Germany Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 23 Germany Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 24 Germany Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 25 France Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 26 France Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 27 France Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 28 UK Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 29 UK Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 30 UK Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 31 Spain Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 32 Spain Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 33 Spain Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 34 Italy Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 35 Italy Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 36 Italy Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 37 Russia Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 38 Russia Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 39 Russia Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 40 Rest of Europe Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 41 Rest of Europe Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 42 Rest of Europe Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 43 Asia-Pacific Avanafil Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 44 Asia-Pacific Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 45 Asia-Pacific Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 46 Asia-Pacific Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 47 China Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 48 China Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 49 China Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 50 Japan Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 51 Japan Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 52 Japan Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 53 India Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 54 India Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 55 India Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 56 South Korea Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 57 South Korea Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 58 South Korea Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 59 Rest of Asia-Pacific Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 60 Rest of Asia-Pacific Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 61 Rest of Asia-Pacific Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 62 Middle East and Africa Avanafil Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 63 Middle East and Africa Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 64 Middle East and Africa Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 65 Middle East and Africa Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 66 GCC Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 67 GCC Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 68 GCC Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 69 North Africa Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 70 North Africa Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 71 North Africa Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 72 South Africa Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 73 South Africa Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 74 South Africa Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 75 Rest of Middle East & Africa Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 76 Rest of Middle East & Africa Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 77 Rest of Middle East & Africa Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 78 Latin America Avanafil Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 79 Latin America Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 80 Latin America Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 81 Latin America Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 82 Brazil Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 83 Brazil Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 84 Brazil Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 85 Argentina Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 86 Argentina Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 87 Argentina Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 88 Rest of Latin America Avanafil Market Revenue, By Deployment Mode, 2021 – 2031 (USD Billion)
TABLE 89 Rest of Latin America Avanafil Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 90 Rest of Latin America Avanafil Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 91 Company Market Ranking
TABLE 92 Regional Footprint
TABLE 93 Product Benchmarking
TABLE 94 Recent Developments
TABLE 95 Winning Imperatives

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Avanafil Market 2021-2031 (USD Billion)
FIG. 4 Global Avanafil Market Geographical Analysis (CAGR %)
FIG. 5 Global Avanafil Absolute Market Opportunity (USD Billion)
FIG. 6 Global Avanafil Market Attractiveness (USD Billion)
FIG. 7 Global Avanafil Market, By Deployment Mode, 2021-2031 (USD Billion)
FIG. 8 Global Avanafil Market, By Application, 2021-2031 (USD Billion)
FIG. 9 Global Avanafil Market, By End-User, 2021-2031 (USD Billion)
FIG. 11 Research Methodology
FIG. 12 Research Process
FIG. 13 Bottom-Up Approach
FIG. 14 Top-Bottom Approach
FIG. 15 Market Dynamics Overview
FIG. 16 Porter's Five Forces Analysis
FIG. 17 Value Chain Analysis
FIG. 18 Macroeconomic Analysis
FIG. 19 Global Avanafil Market Revenue Share, By Deployment Mode, 2021 and 2031 (%)
FIG. 20 Global Avanafil Market Revenue Share, By Application, 2021 and 2031 (%)
FIG. 21 Global Avanafil Market Revenue Share, By End-User, 2021 and 2031 (%)
FIG. 22 Global Avanafil Market Revenue Share, By Geographic Regions, 2021 and 2031 (%)
FIG. 23 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 24 North America Avanafil Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 25 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 26 Europe Avanafil Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 27 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 28 Asia-Pacific Avanafil Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 29 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 30 Middle East & Africa Avanafil Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 31 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 32 Latin America Avanafil Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 33 Key Strategic Development
FIG. 34 Key Facts
FIG. 35 Financial Overview
FIG. 36 SWOT Analysis